MICHAEL ARONSTEIN - 31 Dec 2021 Form 5 Insider Report for AngioGenex, Inc.

Role
Director, CHAIRMAN, 10%+ Owner
Signature
/s/ MICHAEL ARONSTEIN
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
+$134,362,775,000
Form type
5
Filing time
15 Feb 2022, 15:41:38 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGGX Common Stock Award $6,250,000,000 +250,000 +4.3% $25000.00* 6,000,000 23 Oct 2019 Direct
transaction AGGX Common Stock Award $6,250,000,000 +250,000 +4.3% $25000.00* 6,000,000 30 Dec 2019 Direct
transaction AGGX Common Stock Award $125,000,000 +25,000 +0.41% $5000.00* 6,130,555 03 Mar 2020 Direct
transaction AGGX Common Stock Award $500,000,000 +50,000 +0.82% $10000.00* 6,130,555 05 Aug 2020 Direct
transaction AGGX Common Stock Award $555,550,000 +55,555 +0.91% $10000.00* 6,130,555 08 Oct 2020 Direct
transaction AGGX Common Stock Award $40,000,000,000 +400,000 +5.6% $100000.00* 7,507,827 02 Mar 2021 Direct
transaction AGGX Common Stock Award $5,681,800,000 +227,272 +3.1% $25000.00* 7,507,827 08 Jun 2021 Direct
transaction AGGX Common Stock Award $75,000,000,000 +750,000 +11% $100000.00* 7,507,827 31 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGGX Stock Option Award $105,000 +3,000,000 $0.0350* 3,000,000 15 Jan 2019 Common Stock 3,000,000 $0.3500 Direct
transaction AGGX Stock Option Award $260,000 +2,000,000 +67% $0.1300* 5,000,000 02 Sep 2021 Common Stock 2,000,000 $0.1300 Direct
transaction AGGX Convertible Note Award $60,000 +240,000 +4.8% $0.2500* 5,240,000 02 Nov 2021 Common Stock 240,000 $25.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.